News
Several anti-obesity drugs, including Ozempic, Wegovy and Mounjaro, have created buzz in the Indian markets. But are they really approved for use in India? What are their side-effects? And how much do ...
A WOMAN who shed a whopping 6st in just nine months has shared the secret behind not pilling back all the pounds when eating out. Lucy Davies kickstarted her weight loss journey with the popular ...
"My scene was supposed to be funny, and it got nothing in the f---ing Chinese Theatre," the comedian says while discussing ...
When glucagon-like peptide-1 receptor agonists (GLP-1s) like semaglutide (Wegovy) and liraglutide (Saxenda) were approved for ...
In a study on people with obesity and asthma, researchers saw “significant” improvements in the asthma scores of people who ...
Researchers in a recent study discovered that people taking medications to help them lose weight might experience weight gain ...
Explore more
GoodRx reports that insurance coverage for GLP-1 medications varies. It's more likely when prescribed for FDA-approved uses ...
Editors: Story has been updated from original, with material from the president of the Arizona Obesity Organization. Slug: ...
The diabetes drugs Ozempic and Wegovy have been linked to an increased risk of sudden vision loss and blindness due to a rare ...
A spokesperson said: “Results from the STEP trials demonstrate that weight regain is likely once medication is stopped.
More than 80 U.S. lawmakers asked the FDA to stop counterfeit GLP-1 drugs linked to Chinese suppliers from entering the ...
Those projections of reduced spending were reflected in a survey released in December by data analytics firm Numerator that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results